| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.092 | 0.009 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.087 | 0.01 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.01 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.092 | 0.01 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.02 |